Several reports have demonstrated that prolongation of the QT interval is associated with sudden cardiac death (SCD). However, it is unknown whether any of the components within the QT interval are responsible for its association with SCD.
T
he association between QT-interval prolongation and sudden cardiac death (SCD) has been reported in several populations. [1] [2] [3] Although the QT interval is traditionally used as a marker of ventricular repolarization, it encompasses phases 0 to 3 of the ventricular cardiac action potential and involves both depolarizing and repolarizing currents. 4, 5 Even within the repolarization components of the QT interval, regional differences in electrophysiological properties (eg, repolarization heterogeneity) and prognostic significance have been reported. 6 Accordingly, the precise component within the QT interval that is associated with SCD remains unclear.
To address this gap in knowledge, an in-depth examination of the association between the individual components of the QT interval and SCD is warranted to determine whether the risk of SCD is triggered by abnormalities of ventricular depolarization or repolarization. A better understanding of the mechanistic association between the QT interval and SCD may guide the development of novel treatments and facilitate the implementation of effective prediction in individuals who are high risk for developing SCD. Therefore, we examined the association between the individual QT-interval components and SCD in the ARIC study (Atherosclerosis Risk in Communities).
METHODS

Study Design and Population
The ARIC study prospectively enrolled 15 792 communitydwelling men and women between 45 and 64 years of age. 7 Four field centers across the United States (Washington
WHAT IS KNOWN?
• Prolongation of the QT interval has been associated with an increased risk for sudden cardiac death in several population-based cohort studies.
WHAT THE STUDY ADDS?
• Because of heterogeneity in QT-interval components (R-wave onset to R-peak, R-peak to R-wave end, ST-segment, T-wave onset to T-peak, and T-peak to T-wave end), the risk of sudden cardiac death was examined for each QT-interval component.
• The findings of this analysis demonstrated that
the association between the QT interval and sudden cardiac death is driven by prolongation of the T-wave onset to T-peak component.
• These data provide a better understanding of the mechanistic link between the QT interval and sudden cardiac death and possibly will improve the prediction of individuals who are high risk for sudden cardiac death in the community.
County, MD; Forsyth County, NC; Jackson, MS; and suburban Minneapolis, MN) recruited participants between 1987 and 1989. Participants returned for 4 follow-up examinations (1990-1992, 1993-1995, 1996-1998, and 2011-2013 ) and continue to be followed via semiannual telephone calls to ascertain study end points. End points are further ascertained from examination of lists of hospital discharges that include any cardiovascular diagnoses from hospitals in the study communities. For this analysis, we excluded the following participants: (1) participants with major ventricular conduction abnormalities (eg, complete left or right bundle branch blocks), pacemakers, Wolff-Parkinson-White syndrome, QRS duration ≥120 ms, or with extremes of absolute QT-interval duration (>600 or <200 ms); (2) the few ARIC participants with race other than black or white; (3) participants with history of coronary heart disease or heart failure; (4) participants who reported the use of class I or III antiarrhythmic drugs at baseline or QT-prolonging medications. Similar to prior work in ARIC, the small number of black participants from Washington County and Minneapolis were excluded. Participants provided informed consent before enrollment, and this study was approved by the institutional review boards at each participating institution.
Baseline Characteristics
Age, sex, and race were self-reported. Tobacco use was defined as current or former cigarette smoking. Diabetes mellitus was defined as a fasting glucose level ≥126 mg/dL (or nonfasting glucose ≥200 mg/dL), a self-reported physician diagnosis of diabetes mellitus, or the use of diabetes mellitus medications. Systolic blood pressure was obtained from each participant using sphygmomanometers to measure 3 readings in the upright position after 5 minutes of rest. The average of the last 2 blood pressure measurements was used as the final reading. Antihypertensive medication use was self-reported. Body mass index was defined as the weight in kilograms divided by the square of the height in meters. Low-density lipoprotein cholesterol levels were calculated indirectly using cholesterol values assayed from serum samples obtained at the baseline study visit. Left ventricular hypertrophy was defined by the Cornell criteria (R-wave amplitude AV L plus S-wave amplitude V 3 ≥2.8 mV men and ≥2.0 mV women) using baseline ECG data. 9 In addition to the automatically calculated QT interval, the median value in all 12 leads for the following individual QT-interval components were computed: R-wave onset to R-peak, R-peak to R-wave end, ST-segment, T-wave onset to T-peak, and T-peak to T-wave end. Each component was examined per 1-SD increase to provide comparability among different components. Heart rate was included as a covariate in all models to provide heart rate correction using a linear regression approach as recommended by current ECG guidelines. 10 Prolonged QT interval was defined as ≥460 ms for women and ≥450 ms for men using a linear regression-based formula as recommended by the same guidelines, 10 and hence, we used the Framingham formula (QT=QT+0.154×[1-(60/heart rate)]).
QT-Interval Components
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Sudden Cardiac Death
The primary outcome of this analysis was physician-adjudicated SCD. The methods for ascertainment of SCD events have been described previously. 12 Briefly, SCD was defined as a sudden pulseless condition presumed because of a ventricular tachyarrhythmia in a previously stable individual without evidence of a noncardiac cause of cardiac arrest. All cardiac arrest events occurred out of the hospital or in an emergency room. To identify SCD cases, fatal cardiovascular deaths that occurred by December 31, 2012, were reviewed and adjudicated by a committee of electrophysiologists, general cardiologists, and internists in 2 phases. In the first phase, cardiovascular deaths occurring on or before December 31, 2001, were adjudicated by 5 physicians. In the second phase, cardiovascular deaths occurring between January 1, 2002, and December 31, 2012, were adjudicated by a committee of 11 physicians. All cases of fatal cardiovascular deaths that occurred out of the hospital or in an emergency room were reviewed. In the first phase, all in-hospital cardiovascular deaths also were reviewed. In the second phase, in-hospital deaths were reviewed only if cardiac arrest with cardiopulmonary resuscitation occurred before hospitalization. Available data from death certificates, informant interviews, physician questionnaires, coroner reports, medical history, and hospital discharge summaries were reviewed. Additionally, circumstances surrounding the event were used to classify cases of SCD. In both phases of SCD adjudication, each event was adjudicated independently by 2 physicians, and was classified as being definite SCD, possible SCD, definite non-SCD, and unclassifiable. If disagreement existed between the first 2 reviewers, a third reviewer independently reviewed the event to provide the final classification. Cases of SCD included definite and probable cases through December 31, 2012.
Statistical Analysis
Baseline characteristics were compared between those who did and did not develop SCD. Categorical variables were reported as frequency and percentage, whereas continuous variables were recorded as mean±SD. Differences between groups were tested using the χ 2 method for categorical variables and the student t test for continuous variables. Follow-up time was defined as time between the baseline examination until SCD, death, loss to follow-up, or end of follow-up. Cox regression was used to examine the association between each QT-interval component (per 1-SD increase) and SCD, separately. Models were constructed as follows: model 1 adjusted for age, sex, race, and heart rate; model 2 adjusted for model 1 covariates plus smoking, systolic blood pressure, diabetes mellitus, body mass index, low-density lipoprotein cholesterol, antihypertensive medication use, and left ventricular hypertrophy. We also examined the relationship of each component with SCD using a restricted cubic spline model with knots incorporated at the 5th, 50th, and 95th percentiles, separately. 13 A likelihood ratio test was computed to test for linearity on the relationship between each QT-interval component and SCD. Several sensitivity analyses were performed. A secondary analysis was performed for prolonged QT-interval components (>95th percentile versus ≤95th percentile). The correlation of the QT interval and JT interval with T-wave onset to T-peak was examined using the Pearson correlation coefficient (r). A separate analysis was performed using QT-interval components computed from lead V 5 in isolation. We performed a separate analysis with all QT-interval components included in the same model to determine whether each component retrained its prognostic significance independent of the other components. Additionally, because of the difficulty in measuring the onset of the T-wave, an analysis was performed using R-wave end to T-peak. To adjust for multiple hypothesis testing in the initial set of analyses evaluating the risk of SCD associated with each QT-interval component treated as continuous variables, a Bonferroni correction was used corresponding to a P value for significance of 0.05/5=0.01. For the remaining analyses, 2-tailed P values <0.05 were considered statistically significant. The test statistic of Grambsch and Therneau was used to check the proportional hazards assumption, 14 and this was not violated in our analysis. SAS, version 9.4 (Cary, NC), was used for all analyses.
RESULTS
A total of 12 241 participants (54±5.7 years; 26% black; 55% women) were included in this study. Baseline characteristics stratified by SCD are shown in Table 1 . The mean QT interval for the entire cohort was 408±27 ms (median, 408 ms; 25th-75th percentiles, 390-426). The distribution for the QT interval is shown in Figure 1 .
During a median follow-up of 23.6 years (25th-75th percentiles, 20.4-24.3), a total of 346 cases of SCD occurred (incidence rate per 1000 person-years, 1.3; 95% confidence interval [CI], 1.2-1.5). Although prolonged QT interval overall was associated a 49% increased risk of SCD (hazard ratio [HR], 1.49; 95% CI, 1.01-2.18; P=0.043), only T-wave onset to T-peak (per 1-SD increase: HR, 1.19; 95% CI, 1.06-1.34; P=0.0028) was associated with an increased risk of SCD after multivariable adjustment (Table 2) . Similar results were observed when we examined the risk of SCD associated with each QT-interval component when it exceeded the 95th percentile of the distribution of that component (Table 2 ). The QT interval (r=0.41; P<0.001) and JT interval (r=0.57; P<0.001) correlated with T-wave onset to T-peak.
The graphical representations of the risk of SCD across each QT-interval component are depicted in Figures 2, 3, and 4 . As shown, the risk of SCD did not vary across the QRS complex (R-wave onset to R-peak, R-peak to R-wave end; Figure 2 ) or ST-segment (Figure 3) . However, the risk of SCD was shown to increase across T-wave onset to T-peak values (Figure 4) . T-wave onset to T-peak was the only component that demonstrated a linear relationship with SCD (likelihood ratio test for linearity; P=0.0028).
The relationship between T-wave onset to T-peak (per 1-SD increase: HR, 1.21; 95% CI, 1.06-1.37) and SCD did not depend on the other QT-interval components when they were included in the same model (Table 2) . Additionally, when we limited the analysis to lead V 5 , T-wave onset to T-peak (per 1-SD increase: HR, 1.15; 95% CI, 1.03-1.27) was the only QT-interval component associated with SCD ( Figure I in the Data Supplement). Also, R-wave end to T-peak was associated with SCD 
DISCUSSION
In this analysis from ARIC, and similar to prior reports, [1] [2] [3] prolonged QT interval was associated with an increased risk of SCD. However, we have demonstrated that this association is driven by prolongation of the T-wave onset to T-peak component. Overall, the findings in this report suggest that shifting the focus from the entire QT interval to its individual components will help further refine SCD risk prediction.
Although several studies examined the association between the QT interval and SCD, [1] [2] [3] to our knowledge, only one report has attempted to determine whether any of the QT-interval components are associated with SCD in the community. A case-control study from the Oregon sudden unexpected death study found that T-peak to T-wave end was associated with SCD in people with and without normal QRS duration. 15 In contrast with the current study, we did not find an association with T-peak to T-wave end duration in people with normal QRS duration. The portion of the T-wave associated with SCD was T-wave onset to T-peak. Explanations for the conflicting results possibly are related to varia- tion in study design (eg, case-control versus prospective cohort) and the racially diverse study population of men and women in ARIC. Additionally, QT-interval components were measured manually in the Oregon sudden unexpected death study and automatically in the ARIC study. Nevertheless, the shared conclusion that could be derived from the Oregon sudden unexpected death study and the finding of the current report is that repolarization abnormalities (whether T-wave onset to T-peak or T-peak to T-wave end), rather than depolarization abnormalities, are more important markers of SCD risk in the general population. Additionally, the usefulness of the entire QT interval as a marker of increased SCD risk should be reconsidered.
The potential link between ventricular repolarization abnormalities in the general population and SCD remains unclear. Insights have been gained from genetic conditions, such as congenital long QT syndrome, in which these inherited channelopathies are associated with delayed ventricular repolarization because of lengthening of the ventricular action potential. 16, 17 Subsequently, early afterdepolarizations generate premature action potentials that lead to fatal ventricular arrhythmias (eg, polymorphic ventricular tachycardia and ventricular fibrillation). Although T-peak to T-wave end has been implicated as the time when ventricular cells are vulnerable to the occurrence of early afterdepolarizations and development of fatal ventricular arrhythmias, 15 the data in this report suggest that prolongation of the T-wave onset to T-peak time is a more important marker of SCD risk. Other explanations are related to delayed epicardial repolarization in which vulnerability to early afterdepolarizations is present. 5 This possibly is true for patients without genetic disorders that predispose to fatal ventricular arrhythmias because abnormalities of T-peak to T-wave end have been associated with these events in people with hypertrophic cardiomyopathy and congenital long QT syndrome. 18, 19 This would suggest that T-peak to T-wave end is a more important marker of SCD risk in people with the aforementioned Figure 2 . Risk of sudden cardiac death across QRS duration. Each hazard ratio was computed using a restricted cubic spline model with the median R-wave onset to R-peak (A) value of 24 ms as the reference, and for R-peak to R-wave end (B), a median value of 18 ms was used as the reference. Models included the following: age, sex, race, heart rate, smoking, systolic blood pressure, diabetes mellitus, body mass index, low-density lipoprotein cholesterol, antihypertensive medication use, and left ventricular hypertrophy. Dotted lines represent the 95% confidence interval.
inherited conditions, and T-wave onset to T-peak is a more important marker of SCD in the community. However, the hypothesis offered is purely speculative, and further research is needed to understand our findings.
The current analysis should be interpreted in the context of several limitations. Although the ECG measures used in this analysis are not routinely reported on a standard 12-lead tracing, these measures are easily obtained with excellent repeatability for clinical and research purposes. 20 Several baseline characteristics were ascertained by self-reported history and potentially subjected our analyses to misclassification bias. Similarly, it is possible that some cases of SCD were missed, despite rigorous attempts to identify all events. Additionally, we attempted to limit our analysis to people who were free of conditions associated with inherent QT-interval prolongation. However, it is possible that some participants were included because of incorrect classification of these conditions. Furthermore, although we included several covariates in our multivariable models that likely influenced the development of SCD, we acknowledge that residual confounding is possible. Despite these limitations, this is the first report addressing the contribution of the QT-interval components to the risk of SCD in a large community-based population. The physician-adjudicated SCD methodology, long-term follow-up, standardized ECG interpretation, and central automated reading at a core laboratory are just a few of the many strengths of our study.
In conclusion, the findings in this analysis demonstrate that the link between the QT interval and SCD is dependent on prolongation of the T-wave onset to T-peak component. This suggests that the focus of the entire QT interval on SCD risk should be reconsidered because individual markers of abnormal repolarization could be useful in refining SCD risk prediction in the community. Further studies are needed to understand the underlying link between abnormal ventricular repolarization and SCD and whether these markers improve SCD risk prediction. Each hazard ratio was computed using a restricted cubic spline model with the median ST-segment value of 114 ms as the reference and was adjusted for age, sex, race, heart rate, smoking, systolic blood pressure, diabetes mellitus, body mass index, low-density lipoprotein cholesterol, antihypertensive medication use, and left ventricular hypertrophy. Dotted lines represent the 95% confidence interval. 8 cardiac death mortality classification committee members: Nona Sotoodehnia (lead), Selcuk Adabag, Sunil Agarwal, Lin Chen, Raj Deo, Leonard Ilkhanoff, Saman Nazarian, Ashleigh Owen, Kris Patton, and Larisa Tereschchenko.
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